Heart Failure with Preserved Ejection Fraction and Therapeutic Approaches: A Systematic Review and Meta-analysis

References (40)

1. 1 Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting [DOI]
2. 2 2013 ACCF/AHA Guideline for the Management of Heart Failure [DOI]
3. 3 Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction [DOI]
4. 4 Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction [DOI]
5. 5 Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial [DOI]
6. 6 Epidemiology and risk profile of heart failure [DOI]
7. 7 Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study [DOI]
8. 8 Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction [DOI]
9. 9 Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) [DOI]
10. 10 The perindopril in elderly people with chronic heart failure (PEP-CHF) study [DOI]
11. 11 Diastolic Stiffness of the Failing Diabetic Heart [DOI]
12. 12 Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] [DOI]
13. 13 Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure [DOI]
14. 14 Heart Failure With a Normal Ejection Fraction [DOI]
15. 15 Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy [DOI]
16. 16 Statin Therapy May Be Associated With Lower Mortality in Patients With Diastolic Heart Failure [DOI]
17. 17 Effect of Aldosterone Antagonism on Myocardial Dysfunction in Hypertensive Patients With Diastolic Heart Failure [DOI]
18. 18 Effect of Propranolol Versus No Propranolol on Total Mortality Plus Nonfatal Myocardial Infarction in Older Patients with Prior Myocardial Infarction, Congestive Heart Failure, and Left Ventricular Ejection Fraction ≥40% Treated With Diuretics Plus Angiotensin-Converting Enzyme Inhibitors [DOI]
19. 19 Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States [DOI]
20. 20 Effect of Carvedilol on Diastolic Function in Patients with Diastolic Heart Failure and Preserved Systolic Function. Results of the Swedish Doppler-Echocardiographic Study (SWEDIC) [DOI]
21. 21 Elevated Cardiac Troponin Measurements in Critically Ill Patients [DOI]
22. 22 The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction [DOI]
23. 23 Effects of Treatment on Exercise Tolerance, Cardiac Function, and Mortality in Heart Failure With Preserved Ejection Fraction [DOI]
24. 24 Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth [DOI]
25. 25 Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial [DOI]
26. 26 Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors [DOI]
27. 27 Prescription of Beta-Blockers in Patients with Advanced Heart Failure and Preserved Left Ventricular Ejection Fraction. Clinical Implications and survival [DOI]
28. 28 The Effect of Quinapril on Functional Status of Elderly Patients with Diastolic Heart Failure [DOI]
29. 29 Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction — A meta analysis of 7 prospective clinical studies [DOI]
30. 30 Effect of Beta-Blocker Therapy on Rehospitalization Rates in Women Versus Men With Heart Failure and Preserved Ejection Fraction [DOI]
31. 31 Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function [DOI]
32. 32 Long-term outcome after a first episode of heart failure. A prospective 7-year study [DOI]
33. 33 Comparison of Outcomes and Usefulness of Carvedilol Across a Spectrum of Left Ventricular Ejection Fractions in Patients With Heart Failure in Clinical Practice [DOI]
34. 34 Angiotensin-Converting Enzyme Inhibitors Prescription Is Associated With Longer Survival Among Patients Hospitalized for Congestive Heart Failure Who Have Preserved Systolic Function: A Long-Term Follow-Up Study [DOI]
35. 35 Statin Therapy in Patients with Diastolic Heart Failure [DOI]
36. 36 Digoxin and Reduction of Heart Failure Hospitalization in Chronic Systolic and Diastolic Heart Failure [DOI]
37. 37 Relation of β-Blocker Use With Frequency of Hospitalization for Heart Failure in Patients With Left Ventricular Diastolic Dysfunction (from the Heart and Soul Study) [DOI]
38. 38 Mortality and morbidity of newly diagnosed heart failure treated with statins [DOI]
39. 39 Successful treatment of hypertension accounts for improvements in markers of diastolic function − a pilot study comparing hydrochlorothiazide-based and amlodipine-based treatment strategies [DOI]
40. 40 Heart failure with preserved ejection fraction: is this diastolic heart failure?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• A Systematic Review and Meta-Analysis on the Relationships between Extreme Ambient Temperature and All-Cause Mortality Risk: A Time Series Approach — shares topic coverage
• Unmasking the Unexpected: A Case of Acute Pulmonary Edema in Heart Failure with Preserved Ejection Fraction — shares topic coverage
• Diastolic Dysfunction in Preoperative Normotensive Normoglycemic Patients Older than 50 years-A Hospital Based Prevalence Study — shares topic coverage
• Exercise Echocardiography in the Diagnostic Work-up of Unexplained Dyspnoea: A Critical Narrative Review of Physiological Targets, Diagnostic Performance and Unresolved Controversies — shares topic coverage